Bursa Malaysia Securities Berhad (formerly known as Kuala Lumpur Stock Exchange),
Main Board listed TH Group Berhad is a diversified and professionally managed
organisation with a strong presence in traditional businesses while continuing to
increase its presence in the New Economy. Having over 20 years of excellent track
record and driven by a dynamic and professional management team. TH Group has
cemented a solid foundation to cross the bridge between the old and new economy.
TH Group pursues a focused growth strategy by directing expertise towards Technology
and Biohealthcare, building on its strong fundamentals in Plantations and Construction
Services.

To date the Group has cultivated approximately 11,758 hectares of palm oil plantations
in Sabah. The Group also owns and operates a 90 metric tonne crude palm oil mill. On
the construction front, the division is involved in design and build, project management,
engineering services and M&E Services. The technology front is involved in the research
and development of software that is targeted at improving operational efficiency,
facilities management and e-business solutions.

Under biohealthcare, the division operates NCI Cancer Hospital, which is involved in both treatments and clinical trials, the NCI Specialist Clinics, a pharmaceutical distribution division, an FDA compliant biologic contract manufacturing plant and a toxicology plant with GLP standard. Asiaprise Biotech is the flagship company for the Group to develop its healthcare and biotech related business.